Avi Veidman is the founder of Nucleai. Nucleai has raised $50M in total funding. Latest round: Series B. Backed by Section32, Sanofi, Debiopharm.
Avi Veidman is the co-founder and CEO of Nucleai, an AI healthcare startup specializing in precision oncology diagnostics through spatial biology and AI analysis of tissue biopsies. He has guided the company through several funding rounds, securing approximately $50 million in investments.
Full founder directory · Investor directory · Company funding database · Fundraising library